Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Psychoneuroimmunology of Glioblastoma: How Emotional States Shape Tumor Biology.

Created on 14 Oct 2026

Authors

Matheus Vinicius Guimarães de Melo, Thaynara Paula Warren Bezerra, Pedro César de Souza, Vanessa Soares Sales, Michelle Melgarejo da Rosa

Published in

Neuropharmacology. Pages 111225. Oct 13, 2026. Epub Oct 13, 2026.

Abstract

Psychological states profoundly influence physiological processes, with growing evidence linking emotional dysregulation to cancer progression. Within the framework of psychoneuroimmunology, recent findings have shown that chronic stress, depression and anxiety disrupt immune surveillance and promote a pro-inflammatory environment that favors tumor growth. Glioblastoma multiforme (GBM), the most aggressive brain tumor, appears particularly sensitive to these neuroimmune influences. Some stress mediators and neurotransmitters-such as glucocorticoids and catecholamines- modulate the GBM microenvironment, fostering tumor-supportive pathways and epigenetic changes. This comprehensive review synthesizes evidence connecting emotional disturbances and glioma biology, highlighting shared neuroimmune mechanisms and therapeutic opportunities. We propose that integrating psychosocial and neuropharmacological strategies into GBM care could improve patients outcomes by targeting both tumor biology and emotional well-being.

PMID:
42869280
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement